3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Unknown
1
Active not recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Sarcoma
1
CNS
1
Conditions
Gliosarcoma
2
Glioblastoma
2
Central Nervous System Neoplasms
2
Squamous Cell Carcinoma of Head and Neck
1
Sarcoma
1
Radiation Injuries
1
Radiation Fibrosis Syndrome
1
Postoperative Complications
1
Lymphedema
1
Fibrosis
1
Carcinoma, Hepatocellular
1
Breast Neoplasms
1
Brain Neoplasms
1
Interventions
Doxorubicin
19
Radiotherapy
10
Ifosfamide
10
apatinib
9
anlotinib
8
Cyclophosphamide
8
camrelizumab
7
Vincristine
5
Dactinomycin
5
toripalimab
3
Trabectedin
3
Radiation Dose Hypofractionation
3
Ipilimumab
3
Gemcitabine
3
Etoposide
3
Docetaxel
3
selinexor
2
ribociclib
2
envafolimab
2
brostallicin
2
Topotecan
2
Thalidomide
2
Temozolomide
2
Sorafenib
2
Oncolytic Virotherapy
2
Nivolumab
2
Neoadjuvant Therapy
2
Melphalan
2
Magnetic Resonance Spectroscopy
2
Irinotecan
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Unknown
×
Sarcoma
×
Hyperbaric Oxygenation
×
Clear all
NCT00936052
2010-07-16
HBO
Neurological Surgery, P.C.
Phase 2
Unknown
20 enrolled